Name | 2-Butenoic acid, 2-methyl-, (1S,2R)-2-hydroxy-3-[(1S,2R)-2-(7-methoxy-1,3-benzodioxol-5-yl)-1-methyl-2-[[(2Z)-2-methyl-1-oxo-2-buten-1-yl]oxy]ethoxy]-1,2-dimethyl-3-oxopropyl ester, (2Z)- |
---|
Description | Neohelmanthicin A (compound 3A) is a phenylpropanoid compound with antitumor activity. The IC50s of Neohelmanthicin A for inhibiting leukemia cell line EL4, breast cancer cell line S180 and breast cancer cell line MCF7 are 0.13 μM, 7 μM and 23 μM respectively[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C26H34O10 |
---|---|
Molecular Weight | 506.54 |